Jul 23, 2021
Global Specimen Validity Testing Market size was valued at US$ XX Mn in 2019 and the total revenue is expected to grow at XX% through 2020 to 2026, reaching nearly US$ XX Mn.
The global Specimen Validity Testing market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Specimen Validity Testing market report also provides trends by market segments, technology, and investment with a competitive landscape.
Global Specimen Validity Testing Market
To know about the Research Methodology :- Request Free Sample Report
Global Specimen Validity Testing Market Overview
Specimen Validity Testing (SVT) is performed for testing urine samples in order to detect if it has been adulterated, substituted, and diluted. The substitution is carried out by separating water or salt from the samples or specimens and is generally identified by a high level of creatinine or through specific gravity test results. Whereas, adulteration is the addition of other substances in the specimen to cover the presence of drug or to destroy the traces of drug and drug metabolite that are suspected to be present in the specimen. Dilution happens when a large amount of water or fluid is consumed before the collection of the specimen. Drug level concentration below the drug metabolite threshold value can generate negative results. Specimen validity testing plays a very important role in sectors such as healthcare to study behavior and honesty of patients with their doctors.
Specimen validity testing (SVT) and urine drug testing both are important tools in enhancing the safety of the workplace, monitoring medication, and detection of diversion in prescriptions and drug abuse. Therapeutic medications, overuse, and controlled changes to manage chronic problems is a serious issue for both physicians and patients. Various techniques and tools are available to monitor the same such as urine sampling and other screening tests.
Global Specimen Validity Testing Market Dynamics
Prevalence of high drug abuse across the globe, increased number of drug screening labs and diagnostic centers combined with effective testing methods are some crucial factors expected to drive the market. Additionally, illegal consumption of drugs such as marijuana, heroin, cocaine, hallucinogens, and other non-medical alcoholic fluids and psychotropic medications, rising awareness regarding specimen validity testing (SVT), and numerous government initiatives to promote drug screening programs at the workplace are anticipated to contribute significantly to the revenue growth of the market during the forecast period. Law enforcement agencies are adopting SVT as a part of their protocol to detect the presence and traces of illicit drugs in criminals & suspects. It helps law enforcement agencies to study the behavior and cause of why a particular crime is carried out.
Technological advancements and increased inclusion of specimen validity testing in the hiring process, schools & universities, and other public places impacted positively on the market. However, certain factors such as the availability of a large number of labs and diagnostic clinics and substitutes of screening tests combined with the time taken to deliver results are hampering the market growth. Whereas, the time and cost-intensive process of approval for a rapid test is challenging. Moreover, SVT is not standard drug testing at the workplace and point of care testing. Thus, limiting the market growth.
Global Specimen Validity Testing Market Segment Analysis
Global Specimen Validity Testing Market 1
By product & services, the segment of reagents, calibrators, and controls is expected to account for the largest market share in terms of revenue in the global market due to increased demand and purchase of reagents, rising in the number of drug screening tests performed coupled with increasing use of rapid drug screening test kits globally. Reagents are chemicals that are used in labs to detect reactions, measure, or make other substances, some of the common reagents include Ethylene, Methane, Propane, and Ethane. Furthermore, the rise in research and development activities in order to boost the efficacy of specimen validity testing has driven demand for reagents and is projected to further contribute to the growth of the segment.
By type, the specimen validity testing market is segmented into laboratory testing and rapid/POC (Point-of-Care) testing. The segment of laboratory testing accounted for the highest market share. The growth can be attributed to the increased SVT in hospitals and clinics, development in the numbers of screening labs, and rising incidences of drug abuse at the workplace and in households. As laboratory tests are part of routine check-ups and hold very high state and federal regulatory standards. They are cost-saving and provides real-time monitoring. Whilst, rapid/POC testing segment is anticipated to grow as well owing to the benefits offered by point-of-care testing such as quick results, detection of multiple drugs, and increased global demand for rapid/POC drug testing kits.
Based on end-use, the segments of the workplace dominated the specimen validity market mostly because of increased preference for drug screening to make sure employees at the workplace are not on certain medications such as painkillers, OTC medicines, and other illicit drugs that will affect the work rate and production. Drug screening centres and law enforcement agencies adopted specimen validity testing rapidly to make sure the consumption of the illicit drug is prohibited. And is undertaken to eliminate drug abuse and for rehabilitation treatments.
Global Specimen Validity Testing Market Regional Insights:
Global Specimen Validity Testing Market 2
Based on the region, North America accounted for the largest market share for the Specimen Validity Testing market due to increased consumption of drugs and other illegal substances at school & university, and workplace. Though, consumption of alcohol is common in North American countries such as RUSA, Canada, and Mexico. This caused a rise in abnormal behavior, deaths due to overdose, and depression among the young population. Thus, contributed most to the development of the SVT market. Moreover, the presence of key market players, labs, testing kits, technological advancement, and new screening methods impacted positively on the markets growth. With the USA contributing most.
The Asia Pacific is expected to grow fastest during the protected period this is due to rising government expenditure, robust economic growth, increased construction, and incidences of methamphetamine and ketamine. Over time countries such as India, Sri Lanka, Pakistan, China, and others have noted a rise in the incidence of drug abuse at the workplace and households which prompted authorities to adopt screening tests. According to statistics, alcohol consumption in India was accounted to reach 6.5 billion by 2020 due to high income and urbanization. The rising number of drug screening labs and elevated government expenditure in Research & Development for the healthcare system further propelled the market growth.
Moreover, increased awareness and developed healthcare system in the Middle East & Africa, and South America with the shift of key market players and rise in screeing test at workplace in the region are some of the factors leading towards the market growth of the region.
The objective of the report is to present a comprehensive analysis of the Global Specimen Validity Testing market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the Global Specimen Validity Testing Market dynamics, structure by analyzing the market segments and project the Global Specimen Validity Testing Market size. Clear representation of competitive analysis of key players by Product & Services, price, financial position, Product & Services portfolio, growth strategies, and regional presence in the Global Specimen Validity Testing Market make the report investor’s guide.
Global Specimen Validity Testing Market Scope: Inquire before buying
Global Specimen Validity Testing Market 3
Global Specimen Validity Testing Market, by Region
• North America
• Asia Pacific
• Middle East and Africa
• South America
Global Specimen Validity Testing Market Key Players
• Thermo Fisher Scientific, Inc.
• American Bio Medica Corporation
• Express Diagnostics
• Premier Biotech LabCorp.
• Quest Diagnostics
• ACM Global Laboratories
• Clinical Reference Laboratory (CRL)
• Danaher Corporation
• Fast Track Diagnostics
• Genway Biotech, Inc.
• Abbott Diagnostics
For More Information Visit @:
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This
report can be personalized to meet your requirements. Get in touch with us and our sales team
will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging
opportunities & technologies as well as threats to the companies across the Healthcare,
Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages,
Aerospace and Defense and other manufacturing sectors.
Published: Jul 23, 2021
Published: Jul 23, 2021
Published: Jul 23, 2021
Published: Jul 23, 2021